| Scrip Code | 543245 |
|---|---|
| NSE Symbol | GLAND |
| MSEI Symbol | NOTLISTED |
| ISIN | INE068V01023 |
| Name of company | GLAND PHARMA LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2026 |
| Date of end of financial year | 31-03-2027 |
| Date of board meeting when results were approved | 06-11-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 21-10-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Pharmaceuticals |
| Start date and time of board meeting | 06-11-2026 15:00:00 |
| End date and time of board meeting | 06-11-2026 16:15:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 1,83,358.80 | 3,63,385.90 | |
| Other income | 6,904.80 | 13,027.60 | |
| Total income | 1,90,263.60 | 3,76,413.50 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 64,075.00 | 1,22,895.10 |
| (b) | Purchases of stock-in-trade | 313.60 | 508.10 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 2,592.60 | 6,011.00 |
| (d) | Employee benefit expense | 41,151.10 | 85,550.90 |
| (e) | Finance costs | 713.80 | 1,149.90 |
| (f) | Depreciation, depletion and amortisation expense | 11,501.20 | 22,627.00 |
| (f) | Other Expenses | ||
| 1 | Power and fuel | 5,994.10 | 11,581.80 |
| 2 | Other expenses | 20,828.00 | 39,497.90 |
| Total other expenses | 26,822.10 | 51,079.70 | |
| Total expenses | 1,47,169.40 | 2,89,821.70 | |
| 3 | Total profit before exceptional items and tax | 43,094.20 | 86,591.80 |
| 4 | Exceptional items | 0.00 | 0.00 |
| 5 | Total profit before tax | 43,094.20 | 86,591.80 |
| 6 | Tax expense | ||
| 7 | Current tax | 14,630.80 | 27,180.00 |
| 8 | Deferred tax | (612.20) | (1,359.70) |
| 9 | Total tax expenses | 14,018.60 | 25,820.30 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 29,075.60 | 60,771.50 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 29,075.60 | 60,771.50 |
| 17 | Other comprehensive income net of taxes | 2,376.60 | (295.10) |
| 18 | Total Comprehensive Income for the period | 31,452.20 | 60,476.40 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 29,075.60 | 60,771.50 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 31,452.20 | 60,476.40 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 1,650.10 | 1,650.10 | |
| Face value of equity share capital | 1 | 1 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 17.62 | 36.85 | |
| Diluted earnings (loss) per share from continuing operations | 17.62 | 36.85 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 17.62 | 36.85 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 17.62 | 36.85 | |
| 24 | Debt equity ratio | ||
| 25 | Debt service coverage ratio | ||
| 26 | Interest service coverage ratio | ||
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Refer the signed results uploaded for the complete notes. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2026 | |
| Date of end of reporting period | 30-09-2026 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 3,97,018.20 | |
| Capital work-in-progress | 44,991.60 | |
| Investment property | 0.00 | |
| Goodwill | 29,348.60 | |
| Other intangible assets | 10,140.50 | |
| Intangible assets under development | 263.20 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 0.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 0.00 | |
| Other non-current financial assets | ||
| Total of other non-current financial assets | ||
| Total non-current financial assets | 0.00 | |
| Deferred tax assets (net) | 6,428.20 | |
| Other non-current assets | ||
| 1 | Tax assets, net | 946.40 |
| 2 | Other non-current assets | 13,380.00 |
| 3 | Right-of-use assets | 2,924.50 |
| Total of other non-current assets | 17,250.90 | |
| Total non-current assets | 5,05,441.20 | |
| 2 | Current assets | |
| Inventories | 1,82,861.40 | |
| Current financial asset | ||
| Current investments | 0.00 | |
| Trade receivables, current | 1,92,741.60 | |
| Cash and cash equivalents | 3,44,116.40 | |
| Bank balance other than cash and cash equivalents | 0.00 | |
| Loans, current | 0.00 | |
| Other current financial assets | ||
| Total of other current financial assets | 12,171.10 | |
| Total current financial assets | 5,49,029.10 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | ||
| 1 | Other current assets | 55,342.90 |
| Total of other current assets | 55,342.90 | |
| Total current assets | 7,87,233.40 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 12,92,674.60 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 1,650.10 | |
| Other equity | 10,66,917.20 | |
| Total equity attributable to owners of parent | 10,68,567.30 | |
| Non controlling interest | 0.00 | |
| Total equity | 10,68,567.30 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 6,341.20 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | ||
| 1 | Lease liabilities | 1,698.90 |
| Total of other non-current financial liabilities | 1,698.90 | |
| Total non-current financial liabilities | 8,040.10 | |
| Provisions, non-current | 21,193.50 | |
| Deferred tax liabilities (net) | 20,234.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | ||
| 1 | Other non-current liabilities | 3,242.50 |
| Total of other non-current liabilities | 3,242.50 | |
| Total non-current liabilities | 52,710.10 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 15,620.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 93,820.10 | |
| Total Trade payable | 93,820.10 | |
| Other current financial liabilities | ||
| 1 | Lease liabilities | 1,458.00 |
| 2 | Other financial liabilities | 17,552.20 |
| Total of other current financial liabilities | 19,010.20 | |
| Total current financial liabilities | 1,28,450.30 | |
| Other current liabilities | 32,283.60 | |
| 1 | Other current liabilities | 32,283.60 |
| Total of other current liabilities | 32,283.60 | |
| Provisions, current | 4,973.00 | |
| Current tax liabilities (Net) | 5,690.30 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 1,71,397.20 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 2,24,107.30 | |
| Total equity and liabilites | 12,92,674.60 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2026 | 01-04-2026 | |||||
| Date of end of reporting period | 30-09-2026 | 30-09-2026 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2026 | 01-04-2026 |
| B | Date of end of reporting period | 30-09-2026 | 30-09-2026 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement of defined benefit plans | (436.00) | (184.70) |
| Total Amount of items that will not be reclassified to profit and loss | (436.00) | (184.70) | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (109.80) | (46.30) |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Exchange differences on translation of foreign operations | 2,702.80 | (156.70) |
| Total Amount of items that will be reclassified to profit and loss | 2,702.80 | (156.70) | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | 0.00 | 0.00 |
| 5 | Total Other comprehensive income | 2,376.60 | (295.10) |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2026 | ||||
| B | Date of end of reporting period | 30-09-2026 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 86,591.80 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 1,149.90 | |||||
| Adjustments for decrease (increase) in inventories | (8,523.60) | |||||
| Adjustments for decrease (increase) in trade receivables, current | (2,959.40) | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (10,032.60) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 8,960.10 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 22,627.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 441.80 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (2,858.80) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 11,150.60 | |||||
| Adjustments for share-based payments | 3,983.60 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | (197.40) | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | 0.00 | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 1,440.00 | |||||
| Net cash flows from (used in) operations | 88,031.80 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | 0.00 | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 27,758.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 60,273.80 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 88.70 | |||||
| Purchase of property, plant and equipment | 25,417.70 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 291.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 6,523.20 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 267.80 | |||||
| Net cash flows from (used in) investing activities | (18,829.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 1,305.60 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 0.00 | |||||
| Repayments of borrowings | 2,456.30 | |||||
| Payments of lease liabilities | 873.30 | |||||
| Dividends paid | 32,987.40 | |||||
| Interest paid | 990.70 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (36,002.10) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 5,442.70 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 2,763.10 | |||||
| Net increase (decrease) in cash and cash equivalents | 8,205.80 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 3,35,910.60 | |||||
| Cash and cash equivalents cash flow statement at end of period | 3,44,116.40 | |||||
| Whether results are audited or unaudited | Unaudited |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Declaration of unmodified opinion |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results | Yes |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| 1 | Deloitte Haskins & Sells | Yes | 30-04-2028 | ||
|---|---|---|---|---|---|